1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Emergency Contraception in Finland

Emergency Contraception in Finland

  • April 2013
  • -
  • Euromonitor International
  • -
  • 29 pages

Emergency contraception increased by 3% in current value terms in 2012, reaching €2 million. Consumers are well-aware of the availability of such products without prescription in Finland. Emergency contraception also shows seasonality in Finland, as sales increase in the warmer spring and summer months in particular, peaking after the May Day celebrations and after the Midsummer festival in June. According to the Family Federation, the biggest consumer group in emergency contraception is women...

Euromonitor International's Emergency Contraception in Finland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Emergency Contraception market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Table Of Contents

Emergency Contraception in Finland
EMERGENCY CONTRACEPTION IN FINLAND
Euromonitor International
April 2013

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Emergency Contraception: Value 2007-2012
Table 2 Sales of Emergency Contraception: % Value Growth 2007-2012
Table 3 Emergency Contraception Company Shares by Value 2008-2012
Table 4 Emergency Contraception Brand Shares by Value 2009-2012
Table 5 Forecast Sales of Emergency Contraception: Value 2012-2017
Table 6 Forecast Sales of Emergency Contraception: % Value Growth 2012-2017
Leiras Finland Oy Ab in Consumer Health (finland)
Strategic Direction
Key Facts
Summary 1 Leiras Finland Oy Ab: Key Facts
Summary 2 Leiras Finland Oy Ab: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Leiras Finland Oy Ab: Competitive Position 2012
Executive Summary
Economic Downturn Challenges Growth
Demand for Trendy Products
Tightening Competition
Internet Chemists/pharmacies See An Increase in Sales
Modest, Albeit Steady Growth Is Expected
Key Trends and Developments
Finnish Economy Under Threat
Demographic Changes To Be Considered
Vitamins and Dietary Supplements Faces Strong Competition and Negative Publicity
Obesity and Excess Weight Drive Sales
Internet Chemists/pharmacies Are Liberalised
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 8 Life Expectancy at Birth 2007-2012
Market Data
Table 9 Sales of Consumer Health by Category: Value 2007-2012
Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 11 Consumer Health Company Shares 2008-2012
Table 12 Consumer Health Brand Shares 2009-2012
Table 13 Penetration of Private Label by Category 2007-2012
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 16 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 4 OTC-Switches 2009-2012
Sources
Summary 5 Research Sources












View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...

Global Over The Counter (OTC) Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

Global Over The Counter (OTC) Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

  • $ 4250
  • Industry report
  • November 2016
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...

Global Over the Counter (OTC) Drugs Market

Global Over the Counter (OTC) Drugs Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...

Otc Drugs Markets In China

January 2017 $ 4000

Otc Drugs Companies In China

January 2017 $ 1800

ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.